Teladoc Health, Inc. (4LL.F)
EUR 6.2
(1.97%)
EUR 6.2
(1.97%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.58 Billion USD | 0.52% |
| 2022 | 1.57 Billion USD | 24.13% |
| 2021 | 1.26 Billion USD | -10.91% |
| 2020 | 1.42 Billion USD | 205.7% |
| 2019 | 465.4 Million USD | 12.23% |
| 2018 | 414.68 Million USD | 99.97% |
| 2017 | 207.37 Million USD | 388.8% |
| 2016 | 42.42 Million USD | 68.17% |
| 2015 | 25.22 Million USD | 0.12% |
| 2014 | 25.19 Million USD | 739.87% |
| 2013 | 3 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 1.57 Billion USD | 0.06% |
| 2024 Q2 | 1.02 Billion USD | -35.72% |
| 2023 Q4 | 1.58 Billion USD | 0.59% |
| 2023 Q2 | 1.57 Billion USD | 0.11% |
| 2023 Q3 | 1.57 Billion USD | -0.1% |
| 2023 FY | 1.58 Billion USD | 0.52% |
| 2023 Q1 | 1.57 Billion USD | -0.08% |
| 2022 FY | 1.57 Billion USD | 24.13% |
| 2022 Q4 | 1.57 Billion USD | -0.14% |
| 2022 Q3 | 1.57 Billion USD | -0.15% |
| 2022 Q2 | 1.57 Billion USD | 0.31% |
| 2022 Q1 | 1.57 Billion USD | 24.1% |
| 2021 Q2 | 1.23 Billion USD | -11.17% |
| 2021 FY | 1.26 Billion USD | -10.91% |
| 2021 Q3 | 1.25 Billion USD | 1.34% |
| 2021 Q4 | 1.26 Billion USD | 1.06% |
| 2021 Q1 | 1.39 Billion USD | -2.08% |
| 2020 FY | 1.42 Billion USD | 205.7% |
| 2020 Q2 | 976.11 Million USD | 104.79% |
| 2020 Q3 | 983.81 Million USD | 0.79% |
| 2020 Q1 | 476.65 Million USD | 2.42% |
| 2020 Q4 | 1.42 Billion USD | 44.61% |
| 2019 Q2 | 453.58 Million USD | 2.2% |
| 2019 FY | 465.4 Million USD | 12.23% |
| 2019 Q3 | 459.61 Million USD | 1.33% |
| 2019 Q4 | 465.4 Million USD | 1.26% |
| 2019 Q1 | 443.82 Million USD | 7.03% |
| 2018 Q3 | 408.65 Million USD | 1.46% |
| 2018 Q4 | 414.68 Million USD | 1.48% |
| 2018 Q1 | 210.43 Million USD | 1.48% |
| 2018 Q2 | 402.75 Million USD | 91.39% |
| 2018 FY | 414.68 Million USD | 99.97% |
| 2017 Q4 | 207.37 Million USD | -44.15% |
| 2017 Q3 | 371.33 Million USD | 52.29% |
| 2017 FY | 207.37 Million USD | 388.8% |
| 2017 Q1 | 42.43 Million USD | 0.02% |
| 2017 Q2 | 243.83 Million USD | 474.62% |
| 2016 Q3 | 42.46 Million USD | 56.5% |
| 2016 Q4 | 42.42 Million USD | -0.11% |
| 2016 Q2 | 27.13 Million USD | 8.74% |
| 2016 Q1 | 24.95 Million USD | -1.07% |
| 2016 FY | 42.42 Million USD | 68.17% |
| 2015 Q1 | 24.9 Million USD | -1.17% |
| 2015 Q3 | 25.86 Million USD | -17.65% |
| 2015 Q2 | 31.4 Million USD | 26.13% |
| 2015 Q4 | 25.22 Million USD | -2.46% |
| 2015 FY | 25.22 Million USD | 0.12% |
| 2014 Q4 | 25.19 Million USD | 0.0% |
| 2014 FY | 25.19 Million USD | 739.87% |
| 2013 FY | 3 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| DocCheck AG | 4.95 Million EUR | -31806.877% |
| CompuGroup Medical SE & Co. KGaA | 741.08 Million EUR | -113.407% |
| MeVis Medical Solutions AG | - EUR | -Infinity% |
| Nexus AG | 15.43 Million EUR | -10144.365% |